BVS vs. ACRV
Compare and contrast key facts about Bioventus Inc. (BVS) and Acrivon Therapeutics Inc. Common Stock (ACRV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BVS or ACRV.
Key characteristics
| BVS | ACRV | |
|---|---|---|
| YTD Return | 111.20% | 60.98% |
| 1Y Return | 186.49% | 52.60% |
| Sharpe Ratio | 2.81 | 0.51 |
| Sortino Ratio | 3.62 | 1.75 |
| Omega Ratio | 1.45 | 1.20 |
| Calmar Ratio | 2.45 | 0.66 |
| Martin Ratio | 18.04 | 2.34 |
| Ulcer Index | 10.87% | 23.90% |
| Daily Std Dev | 69.67% | 109.99% |
| Max Drawdown | -95.18% | -85.34% |
| Current Drawdown | -42.06% | -65.86% |
Fundamentals
| BVS | ACRV | |
|---|---|---|
| Market Cap | $773.95M | $259.86M |
| EPS | -$0.61 | -$2.72 |
| Total Revenue (TTM) | $555.06M | $1.88M |
| Gross Profit (TTM) | $365.95M | $1.31M |
| EBITDA (TTM) | $104.14M | -$59.59M |
Correlation
The correlation between BVS and ACRV is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BVS vs. ACRV - Performance Comparison
In the year-to-date period, BVS achieves a 111.20% return, which is significantly higher than ACRV's 60.98% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BVS vs. ACRV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bioventus Inc. (BVS) and Acrivon Therapeutics Inc. Common Stock (ACRV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BVS vs. ACRV - Dividend Comparison
Neither BVS nor ACRV has paid dividends to shareholders.
Drawdowns
BVS vs. ACRV - Drawdown Comparison
The maximum BVS drawdown since its inception was -95.18%, which is greater than ACRV's maximum drawdown of -85.34%. Use the drawdown chart below to compare losses from any high point for BVS and ACRV. For additional features, visit the drawdowns tool.
Volatility
BVS vs. ACRV - Volatility Comparison
Bioventus Inc. (BVS) has a higher volatility of 21.98% compared to Acrivon Therapeutics Inc. Common Stock (ACRV) at 13.06%. This indicates that BVS's price experiences larger fluctuations and is considered to be riskier than ACRV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BVS vs. ACRV - Financials Comparison
This section allows you to compare key financial metrics between Bioventus Inc. and Acrivon Therapeutics Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities